- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- May 2026
- 177 Pages
Global
From €5215EUR$5,850USD£4,510GBP
- Report
- May 2026
- 372 Pages
Global
From €5215EUR$5,850USD£4,510GBP
- Report
- January 2026
- 185 Pages
Global
From €4011EUR$4,500USD£3,469GBP
- Report
- October 2025
- 160 Pages
Global
From €2993EUR$3,358USD£2,588GBP
€3521EUR$3,950USD£3,045GBP
- Report
- July 2025
- 82 Pages
United States
From €3120EUR$3,500USD£2,698GBP
- Report
- May 2025
- 120 Pages
Global
From €5304EUR$5,950USD£4,587GBP
- Report
- January 2026
- 181 Pages
Global
From €3160EUR$3,545USD£2,733GBP
€3511EUR$3,939USD£3,036GBP
- Report
- January 2026
- 188 Pages
Global
From €3160EUR$3,545USD£2,733GBP
€3511EUR$3,939USD£3,036GBP
- Report
- August 2025
- 183 Pages
Global
From €3160EUR$3,545USD£2,733GBP
€3511EUR$3,939USD£3,036GBP
- Report
- August 2025
- 184 Pages
Global
From €3160EUR$3,545USD£2,733GBP
€3511EUR$3,939USD£3,036GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 200 Pages
Global
From €7122EUR$7,990USD£6,159GBP
- Report
- January 2026
- 240 Pages
Global
From €3120EUR$3,500USD£2,698GBP
- Report
- November 2025
- 185 Pages
Global
From €4011EUR$4,500USD£3,469GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2486EUR$2,789USD£2,150GBP
- Report
- December 2025
- 150 Pages
Global
From €4323EUR$4,850USD£3,739GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more